Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Leaf Venture Partners is a leading U.S.-based venture capital firm focused on early and late-stage investments in life sciences and healthcare technology. The firm has invested in over 200 companies since its founding in 2005—including biopharmaceuticals, medical devices, diagnostics/tools, and health IT—with more than $1 billion under management. Its portfolio includes multiple public exits (IPOs) and acquisitions across biotech/healthcare sectors[1][3][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Leaf Venture Partners.